The expression levels of BRCA2, FHIT, MLH1 and p53 in the lymph node metastasis group showed no statistically significant difference with those of the lymph node non-metastasis group. This evidence concerns the gene BRCA2 and metastatic malignant neoplasm in the lymph nodes.